Factory Supply Treat and Prevent Influenza High Purity Oseltamivir Phosphate CAS NO.204255-11-8
- FOB Price: USD: 75.00-75.00 /Gram Get Latest Price
- Min.Order: 100 Gram
- Payment Terms: T/T,Other
- Available Specifications:
Top quality(1-100)Gram
- Product Details
Keywords
- bpc157
- Treat and Prevent Influenza High Purity
- 204255-11-8
Quick Details
- ProName: Factory Supply Treat and Prevent Influ...
- CasNo: 204255-11-8
- Molecular Formula: C16H31N2O8P
- Appearance: White powder
- Application: Oseltamivir Phosphate is an orally act...
- DeliveryTime: 10-12 days
- PackAge: bag
- Port: shanghai
- ProductionCapacity: 10 Kilogram/Day
- Purity: 99%
- Storage: 2-8℃
- Transportation: air
- LimitNum: 100 Gram
Superiority
purity min99%
Large volume discount
Our advantage:
We have PEPTIDES and SARMS WAREHOUSE IN USA and Euro, you can receive order with 3 days without any customs problems.
We offer drop ship to your end clients in worldwide.
Why Choose us:
1). We have our own GMP lab .
2). Warehouses in USA and Euro to support your urgent need.
3). We can customize Peptides and Test Report HPLC and MS are available.
4). / Bank Transfer / Credit Card / Bitcoin / T/T in Advance / LC @ SIGHT / Paypal for your option.
Details
- Product description
Product name |
Oseltamivir phosphate |
CAS No. |
204255-11-8 |
Molecular Formula |
C16H31N2O8P |
Molecular weight |
410.4 |
Grade Standard |
Medicine Grade |
COA |
Avaliable |
- Product introduction
Oseltamivir phosphate is a kind of anti-influenza drugs, under the trade name Tamiflu. Its appearance exhibits as white to yellowish-white powder. It can be divided into type A (alpha) and B (Beta) selective inhibitor of the influenza virus neuraminidase and can prevent the release of virus from infected cells, through inhibiting the activity of the influenza virus neuraminidase, thus achieving the purpose of control of influenza symptoms. Clinically it can be used for treatment of the type A influenza and type B influenza in adults and children of 1 year old or over 1 year old as well as the clinical prevention of influenza A and B in adult and adolescent of 13 year old or over 13 years old.